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We have investigated the age-dependent modifica-
tions in the expression of eight different subunits of the
g-aminobutyric acid, type A (GABAA) receptor (a1, a2,
a3, a5, b2, b3, g2S, and g2L) and all four subunits of
the a-amino-3-hydroxy-5-methylsoxazole-4-propionate
(AMPA) receptor (GluR1–4) in the hippocampus of 24-
month-old rats. All aged hippocampi displayed a re-
markable increase (aged/adult ratio, 3.53 6 0.54) in the
mRNA levels of the short version of the g2 subunit in
parallel with a similar increase in the g2 subunit protein
(aged/adult ratio, 2.90 6 0.62). However, this increase
was not observed in the mature receptor. On the other
hand, the expression of the different a subunit mRNAs
increased moderately with aging, displaying a heteroge-
neous pattern. The most frequent modification con-
sisted in an increase in the expression of the a1 subunit
mRNA (aged/adult ratio, 1.26 6 0.18), in parallel with a
similar increase on the a1 protein (aged/adult ratio,
1.27 6 0.12) and in the a1 incorporated to the assembled
GABAA receptor (tested by immunoprecipitation; aged/
adult ratio, 5 1.20 6 0.10). However, in the same hip-
pocampal samples, no major modifications were ob-
served on the expression of the AMPA receptor
subunits. As a whole, these results indicated the exist-
ence of an increased expression of the GABAA receptor
subunits and a preservation of the AMPA receptor at the
hippocampal formation. These modifications could re-
flect the existence of specific deficiencies (neuronal loss
and/or deafferentiation) on the GABAergic system in the
aged rats.
Normal aging is associated with memory and/or learning
impairments that could reflect modifications at the hippocam-
pal formation (1). The GABAA
1 and AMPA receptors (major
fast inhibitory and excitatory receptor complexes, respectively)
could be implicated in these alterations (2, 3).
Both neurotransmitter receptors are composed of a high
number of subunits in a, probably, pentameric or tetrameric
conformation. The GABAA receptors are formed by the combi-
nation of a total of 19 subunits grouped in eight families: a1–6,
b1–3, g1–3, d, r1–3, e, p, and u (Ref. 5; for a review, see Ref. 4).
The AMPA-preferring ionotropic glutamate receptor is com-
posed by four subunits (GluR1–4) displaying different splicing
isoforms (for a review, see Ref. 6). This high molecular heter-
ogeneity can generate multiple receptor isotypes, displaying
particular physiological and pharmacological properties.
It is known that the sensitivity for benzodiazepines (anxio-
lytic/hypnotic drugs that interact to the GABAA receptor) in-
crease during aging in humans and in rodents (7). Previous
work from our group has demonstrated the existence of aging-
associated modifications in both the pharmacological proper-
ties and the molecular composition of the GABAA receptors in
rat hippocampus (8–10). These changes could reflect a sensiti-
zation process of the GABAA receptor (see also Ref. 11). How-
ever, the age-dependent modifications on the expression of the
different subunits of the GABAA receptor are currently un-
known. This lack of knowledge is probably due to both the high
number of subunits expressed at the hippocampal formation
and the heterogeneity of the aging process. On the other hand,
the excitatory glutamate receptors, especially AMPA-prefer-
ring glutamate receptors, seem to be less vulnerable to normal
aging, as revealed by the absence of modifications on its bind-
ing properties (12–14). Therefore, the hippocampal GABAergic
system seems to be preferentially affected in the aged rats (Ref.
15 and references therein).
Aiming at obtaining an extensive and global knowledge of
the possible age-dependent alterations in the expression of
both GABAA and AMPA receptors, we have quantified, using
reverse transcription (RT)-PCR, the expression of 18 different
mRNAs implicated on both the GABAergic system and the
AMPA receptor in each hippocampal sample. We are aware
that aging also displays anatomical heterogeneity (10, 15, 16),
and with our approach, we cannot resolve these modifications.
However, we have analyzed the expression of eight GABAA
receptor subunits (a1, a2, a3, a5, b2, b3, g2S, and g2L, the
most abundantly expressed subunits at the hippocampal for-
mation) and all four AMPA-preferring glutamate receptor sub-
units (GluR1–4), including their flip and flop variants, together
with both GAD isoenzymes in the same hippocampus from
adults and 24-month-old rats. Furthermore, using the same
samples, we have also quantified the relative abundance of two
subunit proteins (a1 and g2 subunits) of the GABAA receptor
complex that consistently increased during aging. In all, we
have obtained a significant amount of information about the
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age-dependent modifications of the expression of different sub-
units of the two major fast neurotransmitter receptors.
MATERIALS AND METHODS
Hippocampus Isolation—Adult (3 months) and aged (24 months)
Wistar rats were killed by decapitation, and the hippocampi were
rapidly dissected and frozen in liquid N2. The hippocampi were stored
at –80 °C until use.
RNA and Protein Extraction—Total RNA and proteins were ex-
tracted using the TripureTM isolation reagent (Roche Molecular Bio-
chemicals) kit, according to the instructions of the manufacturer. This
procedure allows the isolation of total RNA, DNA, and protein fractions
from a single sample. The contaminating DNA in the RNA samples was
removed by incubation with DNase and confirmed by PCR analysis of
total RNA samples prior to RT. After isolation, the integrity of the RNA
samples were assessed by agarose gel electrophoresis. The yield of total
RNA was determined by measuring the absorbance (260/280 nm) of
ethanol-precipitated aliquots of the samples. The recovery of RNA was
similar for both young and old hippocampi (not shown).
To analyze the protein fraction, the protein pellets obtained using the
TripureTM isolation reagent, from adult and aged hippocampus, were
resuspended in 1% SDS, 10 mM Tris-HCl, pH 7.4. The total recovery and
integrity of these fractions were determined as (17) and SDS-polyacryl-
amide gel electrophoresis.
Competitive RT-PCR—RT was performed in 10 mM Tris-HCl, pH 8.3,
50 mM KCl, 3 mM MgCl2, 10 mM dithiothreitol, 1 mM dNTPs, 1 mM
random hexamers, 50 units of ribonuclease inhibitor, and 100 units of
AMV-RT (Roche Molecular Biochemicals) in a final volume of 20 ml and
1 mg of total RNA as template. After RT, samples were treated with
RNase, and free nucleotides were eliminated using GlassMAX spin
cartridges (Life Technologies, Inc.). As control of the efficiency in the
RT, samples from adult and aged hippocampi were reverse-transcribed
as described above but in presence of 2 mM digoxigenin-dUTP, and the
purified cDNA was dotted on Nylon membranes and developed (see
below). The films were scanned and the adult and aged samples were
compared. The results (aged/adult ratio, 1.10 6 0.40, n 5 11) demon-
strated a similar RT efficiency in both ages.
Competitive RT-PCR was performed basically as described (18).
Briefly, aliquots of hippocampal cDNA (100 ng/tube) and known quan-
tities of internal standards, corresponding to the a1, a2, a3, a5, b2, b3,
g2S, and g2L GABAA receptor subunits, were mixed in different tubes
with increasing amount of internal standards. Each internal standard
consisted of the same sequence amplified in the native subunit, but
modified by the inclusion of a BglII restriction site, cloned into pGEM-1
plasmids (kind gifts from Dr. Dennis R. Grayson) (19). For each GABAA
receptor subunit, the range of internal standard quantities was estab-
lished in control experiments using adult hippocampus. For each sub-
unit, the range was as follows: 10–1000 fg for a1, a3, a5, b2, and b3;
100–1000 fg for a2; and 10–10,000 fg for g2 (S or L isoforms).
The PCR was performed in a final volume of 50 ml, using Taq
polymerase, 2.5 units, in the buffer supplied by the manufacturer
(Ecogen); 1.5, 2, or 3 mM MgCl2, for the a, b, or g subunits, respectively,
including 1 mM each 59 (sense) and 39 (antisense) of the respective
primers pairs (20); and 50 mM dNTPs with the addition of 2 mM digoxi-
genin-dUTP (Roche Molecular Biochemicals). Internal standards and
cDNA were heat-denatured for 5 min at 94 °C, and tubes were kept on
ice until ready for PCR. The PCR was performed with 30 cycles con-
sisting of 94 °C for 45 s, 60 °C for 45 s, and 72 °C for 50 s, followed by
a final elongation period of 5 min at 72 °C in a Techne Progene Thermal
Cycler. The PCR products (5–10 ml) were digested overnight with 10
units of BglII and separated on a 1.7% agarose gel in 0.53 Tris-borate-
EDTA buffer. After electrophoresis, the PCR products were transferred
onto a Hybond-N1 nylon membrane (Amersham Pharmacia Biotech)
using a vacuum blotting system, VacuGeneTM XL (Amersham Pharma-
cia Biotech) for 1 h at 50 mbar of pressure. The nylon membranes were
blocked, incubated with an anti-digoxigenine antibody conjugated with
peroxidase (dilution, 1/20,000; Roche Molecular Biochemicals), washed
with Tween 0.1% in phosphate-buffered saline, and processed for
chemiluminescence detection using the ECL-plus (Amersham Pharma-
cia Biotech) following the instructions of the manufacturer. Films were
developed and scanned with a laser densitometer (Molecular Dynamics,
model 300 A). Bands for both native cDNA (uncut band) and internal
standard (cut band) were analyzed, and the data are the ratio between
internal standard and native cDNA (see Fig. 1). All subunits were
determined in at least duplicate, and for each experiment, a minimum
of one adult and one aged samples were processed and analyzed in
parallel.
Control experiments for the efficiency of the transference, second
antibody dilution, and film exposure were performed. In all cases, we
found a linear correlation between the amount of PCR products and the
detected absorbance on the films (not shown).
Quantification of the AMPA Subunits and Flip/Flop Relative Pro-
portions—The same samples used for the PCR amplification of the
GABAA receptor subunits, from adult and aged rat hippocampus, were
amplified using primers common to GluR1–4 (sense primer, CCTTTG-
GCCTATGAGATCTGGATGTG; antisense primer, TCGTACCAC-
CATTTGTTTTTCA) with 35 PCR cycles, as described (20), but includ-
ing 2 mM digoxigenin-dUTP. The PCR products, 750 bp, (10 ml per
subunit) were digested by BglI, BanII, Eco47III, or EcoRI restriction
enzymes, which specifically cut the GluR1 (300 and 449 bp), GluR2 (478
and 271 bp), GluR3 (359 and 396 bp), or GluR4 (411 and 338) PCR
fragments, respectively. The restriction products were separated on a
1.7% agarose gel and transferred to Hybond membranes, and the films
were generated and processed as described above. Quantification was
performed for each electrophoresis lane, corresponding to a subunit-
specific digestion, by summing the absorbance values of cut and uncut
bands and normalizing to 100%. Thus, the percentage of the cut bands
corresponds to the proportion of GluR1–4 subunits present in the
PCR-amplified product.
The total amount of all four AMPA receptor subunits was estimated
by quantifying the total, undigested PCR products. For comparative
proposes, the results were normalized by the abundance of the b-actin
(see below).
Flip/flop proportion of the GluR1–4 subunits was quantified using
the product of the first PCR (see above) as a template for a second PCR
(in the presence of 2 mM digoxigenin-dUTP). Specific sense primers for
either GluR1, -2, -3, or -4 and the common antisense primer was that
used for the first amplification. The PCR products (632, 639, 628, and
630 bp, corresponding to GluR1, -2, -3 and -4, respectively (both flip and
flop in all cases)) were then cut with subunit specific enzymes (BglI for
GluR1 flip and GluR2 flop, and HpaI for GluR3 flop and GluR4 flop (20,
21)) and processed as described above.
GAD65/67 and b-Actin Quantification—Both isoforms of the glu-
tamic acid decarboxylase (GAD65 and GAD67) were amplified from the
same cDNA samples as for GABAA, and AMPA receptors. For the
detection of GAD65 and GAD67 mRNAs, the following set of specific
primers were used, from 59 to 39: GAD65 sense, TCTTTTCTCCTGGT-
GGTGCC (position 713); GAD65 antisense, CCCCAAGCAGCATCCA-
CAT (position 1085); GAD67 sense, TACGGGGTTCGCACAGGTC (po-
sition 713); GAD67 antisense, CCCCAAGCAGCATCCACAT (position
1159). The same antisense primer was used for the amplification of both
GAD65 and GAD67. This primer had one mismatch with the sequence
of the GAD67, as indicated by the underlined base (21). The PCR
products were processed as described above. The results were normal-
ized by the expression of a housekeeper gene, b-actin.
The b-actin was amplified using the specific primer pairs, from 59 to
39: sense, CGGAACCGCTCATTGCC; antisense, ACCCACACTGTGC-
CCATCTA. PCR was performed in the presence of 2 mM digoxigenin-
dUTP.
In all cases, the GAD65, GAD67, AMPA, and b-actin were amplified,
electrophoresed, and processed in parallel. In addition, samples for
adult and aged rats were also processed and analyzed in parallel. For
quantification, three different cDNA dilutions were used, and 20, 25,
and 30 cycles of PCR were run in order to avoid the problem of band
saturation.
Membrane Preparation and Receptor Solubilization—Hippocampal
membranes from 3- and 24-month-old Wistar rats were prepared by
ultracentrifugation at 100,000 3 g as described elsewhere (8, 22, 23 and
ref. therein) in presence of protease inhibitors: 1 mM EDTA, 1 mM
EGTA, 1 mM dithiothreitol, 1 mM benzamidine, 50 mg/ml trypsin inhib-
itor type II-S, and 50 mg/ml bacitracin.
The GABAA receptor was solubilized at 1 mg of protein/ml, 4 °C for
60 min, with 0.5% (w/v) sodium deoxycholate, 0.5% (w/v) CHAPS, 140
mM NaCl, and 10 mM Tris-HCl, pH 7.5, containing the same protease
inhibitors as above. After centrifugation at 100.000 3 g, for 60 min at
4 °C, the supernatant was collected. Previous work has demonstrated
the absence of subunit redistribution using this solubilization condi-
tions (24).
Antibody Purification and Immunoprecipitations—When needed, the
anti-a1 and anti-g2 antibodies (24, 25) were purified through peptide
affinity columns. The peptides were coupled to CNBr-activated Sepha-
rose 4B (Amersham Pharmacia Biotech). One ml of the different anti-
sera (diluted 1/5 in phosphate-buffered saline) were recirculated over-
night at 4 °C in the corresponding column (1 ml). After washing with
150 ml phosphate-buffered saline, the antibodies were eluted with 50
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mM glycine-HCl, pH 2.3, and the fractions (0.5 ml) were neutralized by
1 M Tris, pH 11, pooled, and dialyzed against 1 liter of phosphate-
buffered saline overnight at 4 °C.
Prior to utilization, saturating amounts (not shown) of the different
antibodies were adsorbed to 50 ml of a suspension of protein A-Sepha-
rose (10% (w/v) in solubilization buffer; see also Refs. 24 and 25). The
immunoprecipitations were done as described (24, 25).
The immunoprecipitation was quantified by determining the binding
activity of 10 nM [3H]flumazenil (total benzodiazepine receptors) in both
pellets and the final supernatants. The binding assays were done es-
sentially as described previously (23).
Immunoaffinity Chromatography—It is known that the g2 subunit
displays an anomalous electrophoretic behavior in SDS-polyacrylamide
gel electrophoresis (26, 27), and it is difficult to detect in Western blots
(28). Thus, the g2 subunit from adult and aged hippocampus was first
immunopurified through anti-g2 affinity columns (our anti-g2 antibody
was made against a peptide of the N-terminal domain of the protein,
and thus, it recognizes both short and long isoforms). The anti-g2
immunoaffinity columns were synthesized as described (25). Fab frag-
ments of the purified anti-g2 antibodies were used in order to avoid any
possible interference with the IgG heavy chain (55 kDa). The Fab
fragments were prepared using papain-agarose (Pierce) as recom-
mended by the manufacturer. The Fab immunoaffinity columns were
synthesized using CNBr-activated Sepharose 4B (Amersham Pharma-
cia Biotech).
For immunopurification of the g2 subunits, the protein fractions
(containing 1% of SDS, see above) were diluted 1/5 with 1% (w/v) Triton
X-100, 140 mM NaCl, 10 mM Tris-HCl, pH 7.4, and aliquots of 50, 100,
and 200 mg of proteins were applied to 200 ml of affinity column. After
overnight adsorption (at 4 °C), the columns were extensively washed
and eluted with 2% SDS in 10 mM Tris-HCl, pH 7.4. The eluted receptor
was electrophoresed and processed for immunoblot (25). For each de-
termination, one adult and one aged hippocampus were processed in
parallel. Importantly, the immunopurification approach was quantita-
tive, because after a first round of immunopurification, no immunore-
action product (Mr 43,000 peptide) (24) was detected in a second round
of anti-g2 immunopurification (see Fig. 3A). For the comparison be-
tween adult and aged rats, three different aliquots were immunopuri-
fied and analyzed in parallel.
Other Methods—Immunoblots, protein determination, and SDS-
polyacrylamide gel electrophoresis were done as described elsewhere
(24, 25). The statistical analysis of the data were performed using
one-way ANOVA or multifactor ANOVA and the Tukey post hoc mul-
tiple comparisons test.
RESULTS
Expression of the GABAA Receptor Subunit mRNAs—The
expression of different subunits of the GABAA receptor was
quantified by competitive RT-PCR using cDNAs from hip-
pocampus of 3-month-old (adult) and 24-month-old (aged) rats.
Fig. 1 shows a representative experiment of the competitive
RT-PCR analysis of the a5 subunit mRNA from one adult and
two aged rats. This experiment illustrates the linearity of the
competitive RT-PCR (in the range selected for each subunit of
the GABAA receptor; see under “Materials and Methods”), the
experimental variability of triplicate measurements, and also
the differences between the adult and the different aged sam-
ples. Thus, using this approach, we have quantified the expres-
sion of eight subunits of the GABAA receptor complex (a1, a2,
a3, a5, g2S, g2L, b2, and b3 subunits; the major subunits
expressed at the hippocampal formation) (29, 30) in a total
population of four adults and five aged rats. As shown, Fig. 2A,
in the adult and aged rats, the expression of the different
GABAA receptor subunits agrees with previous reports using in
situ hybridization (29). It is interesting to note the low inter-
individual variation found in the four adults tested. The coef-
ficients of variation for each subunit (calculated as SD/mean)
were 0.13, 0.11, 0.26, 0.16, 0.39, 0.24, 0.27, and 0.22 for a1, a2,
a3, a5, g2 s, g2L, b2, and b3, respectively (mean, 0.22).
By comparing all subunits in both ages, we observed a sig-
nificant increase in the aged population (multifactor ANOVA F
(1,71) 5 59.66, p 5 0.00001) and also significant differences
between subunits and ages (subunit 3 age, multifactor ANOVA
FIG. 1. Representative quantification of the GABAA receptor a5 subunit mRNA levels in one adult and two different aged
hippocampi. A, representative films generated after the amplification of a constant amount of cDNA (100 ng) in presence of four different amounts
of a5 internal standard. The PCR products were digested by BglII and electrophoresed in agarose gels. The higher molecular size band (338 bp)
corresponded to native cDNA, and the smaller product corresponded to the internal standard products (170 1 165 bp). B, the films (shown in A)
were analyzed by densitometry and the ratio of internal standard (absorbance)/sample cDNA (absorbance) was plotted versus the amount of
internal standard used. The results are expressed as mean 6 S.D. of triplicate measurements. The point of equivalence (also shown in the figure)
was calculated after linear regression of the curves.
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F (7,71) 5 55.36, p 5 0.00001; Tukey p , 0.05). When the
expression of the total mRNA levels for the different subunit
families (i.e. a1 1 a2 1 a3 1 a5, b2 1 b3, and g2S 1 L) was
analyzed, a significant increase in the aged rats was observed
for the a and g2 subunits (Table I). The expression of the
GABAA receptor from aged hippocampus showed an important
high interindividual variability. The coefficients of variation,
calculated as above, for the expression of the different subunits
in the aged rats were 0.20, 0.12, 1.2, 0.26, 0.14, 0.28, 0.26, and
0.24 for a1, a 2, a3, a5, g2 s, g2L, b2, and b3, respectively
(mean, 0.34). This high variability is likely due to the aging
process and not an artifact because of the competitive RT-PCR
(see Fig. 1). Thus, we also analyzed individually the percentage
of variation (versus adult) in the expression of the a and g
subunits. As shown in Fig. 2B, the expression of these GABAA
receptor subunits showed a clear tendency to increase during
aging. In fact, the expression of the g2S subunit increased
notably in the hippocampus from all five tested rats (see also
Fig. 4, in which a new aged sample was analyzed) (ranging
from 190 to 320% of the adult values; mean, 253.8 6 53.9%;
ANOVA F (1,7) 5 69.33, p 5 0.001; Tukey p , 0.01) with no
modifications in the expression of the long splicing version of
this subunit. Consequently, the S/L ratio (1.81 6 0.7 versus
6.3 6 1.9 for adult and aged rats, respectively) also signifi-
cantly increased in the aged hippocampi (F (1,7) 5 21.9, p 5
0.002; Tukey p , 0.05).
On the other hand, the age-dependent modifications in the
expression of the different a subunits were highly heterogene-
ous (see Fig. 2). The most common pattern of variation in the
aged rats was an increase in the a1 subunit mRNA (four of five
animals; ranging from 17 to 50%; mean, 32.5 6 14.7%; signif-
icant difference from adult, ANOVA F (1,6) 5 9.59, p 5 0.02;
Tukey p , 0.05). It is noteworthy that the single aged hip-
pocampus displaying no differences in the a1 level, rat 26, was
also the only aged rat showing a notable increase in the expres-
sion of the a5 subunit (see Figs. 1 and 2; 61.1% over the adult
value). It is also interesting that in most cases (rats 7, 10, and
16), the increment in the a1 subunit was also accompanied by
an increase in other a subunit(s) (see Fig. 2B), such as a2 (rats
10 and 16; 28 and 25% respectively) or a3 (rat 7; 700%).
Expression of the g2 and a1 Subunit Proteins—We next
compared the expression of the proteins corresponding to a1
and g2 subunits, using the protein fractions obtained from the
same hippocampal samples as above (see under “Materials and
Methods”).
Fig. 3C shows the immunoreaction product corresponding to
the immunopurified g2 subunit (43 kDa), which clearly in-
creased in the aged samples (compare lanes 1–3 with 4–6). The
difference between both ages was calculated as the aged/adult
ratio after the densitometrical analysis of the films. As shown
in Fig. 4A, there was a remarkable and significant increase in
the expression of the g2 subunit protein (aged/adult ratio,
2.90 6 0.62, n 5 6, ranging from 1.7 to 3.3; ANOVA F (1,8) 5
26.43, p 5 0.0009; Tukey p , 0.01). This increase was similar
to that detected at the mRNA level (g2S1L, aged/adult ratio,
2.40 6 0.40, n 5 6, Fig. 4A). When these results were analyzed
individually (Fig. 4B), the alterations in mRNA and protein
levels for the GABAA receptor g2 subunit were found to vary in
parallel.
The a1 subunit was directly quantified by Western blots. The
anti-a1 antibody immunoreacted with a Mr 51,000 band (Fig.
3B, corresponding to the a1 subunit; see also Refs. 24 and 25),
and the immunoreaction product increased with the amount of
protein loaded in the gel. As also shown (Fig. 3B), no signal was
detected in absence of antibody or by preincubation of the
anti-a1 antibody with the corresponding peptide (data not
shown, but see Ref. 25). As shown (Fig. 3D), in the sample from
adults, the anti-a1 antibody immunoreacted with a major 51-
kDa band and with a faint band of 53–54 kDa. This minor
component was not observed using total proteins from the
adult rat cortex (Fig. 3, B and D, CTX), membranes isolated
from different rat brain areas, including hippocampus (31), or
in immunopurified receptors (see Ref. 25; also see Ref. 32).
Interestingly, in all aged hippocampi, this 53–54-kDa band was
strongly and consistently recognized by the anti-a1 antibody
(see Fig. 3D). Furthermore, this 53–54 kDa band was observed
in the aged rats even using purified (through peptide columns)
anti-a1 antibody (not shown). In the aged samples, the inten-
sity of this immunoreaction product parallels that of the 51-
kDa band. In fact, the 53–54-kDa band represented the 28.0 6
5.8%, n 5 6, of the 51 kDa. Although this band could be a
FIG. 2. Age-dependent modification in the expression of the
hippocampal GABAA receptor subunits. A, shown are the quanti-
tative levels of the mRNAs coding for eight GABAA receptor subunits
from four adult (open circles) and five aged (closed circles) rat hip-
pocampi. The results are shown individually and as mean 6 SD (bars).
Note the difference in scale for both axis. B, the percentage of variation
(in relation to the adult values) of the a and g2 (S and L version)
subunits was determined individually for each analyzed rat. The coef-
ficient of variation of the adults for these subunits was also indicated in
the figure.
TABLE I
Age-dependent modifications in the total mRNA content of the
different subunit families of the hippocampal GABAA receptor
The total expression of the different subunit families was calculated
as the sum of the mRNA content of the different subunits tested (e.g.
a1 1 a2 1 a3 1 a5; b2 1 b3; g2s 1 g2L). The results are mean 6 S.D.
of four and five different experiments for adult and aged rats, respec-
tively.
Age
Total mRNA (fg/0.1 mg cDNA)
a subunits b subunits g2 subunits
3 months 2157 6 136 1310 6 158 3717 6 917
24 months 2563 6 107a 1318 6 236 9284 6 1237b
(119.0 6 5.1%) (1250 6 48%)
a ANOVA F (1,7) 5 24.94, p 5 0.002; Tukey p , 0.05.
b ANOVA F (1,7) 5 55.7 p 5 0.0001; Tukey p , 0.01.
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different glycosylation form of the a1 subunit (32), the precise
nature of this band is currently unknown and was not consid-
ered for quantification.
The quantification of these experiments, shown in Fig. 5A,
indicated the existence of a moderate (aged/adult ratio, 1.27 6
0.12, ranging from 1.05 to 1.40, n 5 6) but significant (ANOVA
F (1,10) 5 4.9, p 5 0.04; Tukey p , 0.05) increase in the total
content of a1 subunit in the aged hippocampus. Furthermore,
the age-dependent increase in the expression of the a1 subunit
also correlates with the variation in the mRNA levels (aged/
adult ratio, 1.26 6 0.18, n 5 5). When the data were analyzed
individually (see Fig. 5B), variation on the mRNA levels was
also reflected by a similar modification at the protein level (e.g.
rat 26).
Age-dependent Modifications of the Native GABAA Receptor
Complex—We also tested the effect of aging in the expression of
these two subunits, g2 and a1, assembled in native GABAA
receptors. To this end, we analyzed the [3H]flumazenil binding
activity (10 nM) immunoprecipitated by anti-g2 and anti-a1
antibodies from hippocampal membranes of a new population
of four adult and four aged hippocampi. The results (see Table
II) demonstrated that both the [3H]flumazenil total binding
activity and the anti-g2 immunoprecipitated binding activity
(expressed in pmol/mg of solubilized protein) significantly de-
FIG. 3. The protein levels of both g2 and a1 subunits increased in the aged hippocampus. The levels of g2 and a1 subunit proteins were
determined using specific antibodies by immunoaffinity or immunoblot experiments. A, control experiments showing that the anti-g2 immuno-
affinity columns retained most, if not all, of the g2 subunit in single round of immunopurification. The protein fraction, obtained after RNA
isolation of an adult hippocampus, was immunopurified through 200 ml of anti-g2 affinity column. The supernatant of this purification was used
in a second round of incubation using the same amount of anti-g2 affinity column. Both columns were washed and eluted with 2% SDS. The
presence of the g2 subunit was analyzed by Western blot using a 1/5000 dilution of anti-g2 antibody. As shown, a clear 43-kDa band was detected
in the first immunopurification (control), whereas no reaction products were detected after the second immunopurification (depleted). B, Western
blot analysis of the a1 subunit using cortical membranes. Two different amounts of membranes were subjected to Western blot with a 1/1000
dilution of anti-a1 antibody. This antibody recognized a band of 51 kDa (a1), the immunoreaction product increased in function of the protein
loaded, and this product is absent in absence of primary antibody or in presence of anti-a1 plus peptide (not shown). C, representative experiment
of the anti-g2 (200-ml affinity column) immunopurification procedure using three different amount of proteins (50, 100, and 200 mg) from adult
(lanes 1–3) and aged (lanes 4–6) hippocampus processed in parallel. Note the clear increase of the anti-g2 immunoreaction products in the aged
sample. A control of the anti-g2 immunoaffinity column, in the absence of sample (lane 7), was also included. D, Western blot analysis of the a1
content of a fixed amount of protein (15 mg) from three adults (A2, A3, and A4: lanes 1, 4, and 7, respectively) and 7 aged samples (O1, O7, O10,
O12, O26, O16, and O26: lanes 2, 3, 5, 6, 8, 9, and 10, respectively). This experiment was repeated three times, in a similar configuration, but testing
all four control hippocampus. Note the clear difference between the adult and aged samples on the pattern recognized by anti-a1 antibody.
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creased in all four aged hippocampi tested. On the other hand,
after two rounds of incubation, the anti-g2 antibody immuno-
precipitated most, if not all, the [3H]flumazenil binding activity
in both ages (90.9 6 7.2% and 91.5 6 3.1% for adult and aged
hippocampi, respectively, see Table II) (see Ref. 23). As also
shown (Table II), there was a slight (and not statistically sig-
nificant) decrease on the [3H]flumazenil binding activity im-
munoprecipitated by the anti-a1 antibody in the aged hip-
pocampus. This decrease was lower than that expected by the
reduction of the total [3H]flumazenil binding observed in the
same membrane preparation (–23.8 versus –8.6% for total and
anti-a1 immunoprecipitated binding activity, respectively; see
Table II). As a consequence, the proportion of [3H]flumazenil
binding activity immunoprecipitated by anti-a1 antibody in-
creased significantly in the aged samples (54.5 6 3.8 versus
65.1 6 5.6% for adult and aged; aged/adult ratio, 1.20 6 0.10;
see Table II). Interestingly, the increase in the immunoprecipi-
tation by anti-a1 was observed in three of the four aged hip-
pocampal samples tested, emphasizing the heterogeneity of the
aging process at the hippocampal formation (the individual
data were 57.8, 71.4, 66.4, and 65.0% for the aged samples).
These results demonstrated that the age-dependent increase
in the g2 subunit, mRNA and protein, was not reflected by a
similar increase of the g2 incorporated in the mature GABAA
receptor. Thus, the amount of g2 subunit, lacking benzodiaz-
epine binding activity, should increase in the aged hippocam-
pus. We tested this possibility by quantifying the volume (in ml)
of anti-g2 antiserum needed to immunoprecipitate a fixed (and
identical in both ages) amount of [3H]flumazenil binding activ-
ity. As expected, Fig. 6, the immunoprecipitation curves were
clearly shifted to the right with no changes in the maximal
immunoprecipitation (see also Ref. 23) (64.1 6 3.6%, n 5 3, and
58.5 6 2.1%, n 5 3, for adult and aged hippocampi, respective-
ly). The curves were fitted to a monoexponential decay func-
tion, and the volume of antibody that produces a half-maximal
immunoprecipitation was determined. The volume of anti-g2
for half-maximal immunoprecipitation was 3.3 6 0.7 ml, n 5 3,
and 8.5 6 0.7 ml, n 5 3, for adult and aged hippocampus,
respectively (significant difference between both ages; ANOVA
F (1,4) 5 82.64, p 5 0.0008; Tukey p , 0.01). These results
demonstrated the existence of a significant increase in the
amount of g2 subunit that exhibit no binding activity (probably
unassembled subunit). This increase (aged/adult ratio, 2.60 6
0.21) is similar to that observed for g2S version at the mRNA
level (3.53 6 0.54) and the g2 protein (2.90 6 0.62).
Expression of the AMPA Receptor Subunits—The relative
proportion of the different subunits of the AMPA receptor
(GluR1–4) was studied using the cDNA from the same adult
and aged hippocampal preparations described in Fig. 2. As
shown in Fig. 7A, the relative proportion of the different AMPA
receptor subunits, from both adult and aged hippocampus,
agree with that previously reported (33). As also shown, no
gross changes with aging were detected. Similarly to the
FIG. 4. Age-related alterations on the expression of the g2 sub-
unit. A, shown are the age-dependent variations, expressed as aged/
adult ratio, on g2 subunit mRNA (short 1 long isoforms) and protein.
The mRNA data were taken from Fig. 2 and protein variation were
calculated from experiments similar to that shown in Fig. 3C. Data are
presented individually (closed circles) or as mean 6 SD (open bars). B,
the variations on the aged population (aged/adult ratio) in both the g2
mRNA (open columns) and protein (hatched columns) were represented
individually for each tested rat.
FIG. 5. Age-related alteration on the expression of the a1 sub-
unit. A, shown is the variation (aged/adult ratio) of the mRNA and
protein corresponding to the a1 subunit (see legend of Fig. 4 for more
details). Data are presented individually (closed circles) or as mean 6
SD (open bars). B, the variations on the aged population (aged/adult
ratio) in both the a1 mRNA (open columns) and protein (hatched col-
umns) were represented individually for each tested rat. N.T., not
tested.
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GABAA receptor, the coefficient of variation increased with
aging (0.05, 0.04, 0.04, and 0.5 for GluR1–4 in adults, respec-
tively (mean, 0.15), and 0.18, 0.05, 0.12, 0.66 for the same
subunits in the aged rats (mean, 0.25)) indicating the hetero-
geneity of the aging process. Considering all subunits and both
age groups, Fig. 7A, significant differences were observed (Mul-
tifactor ANOVA Subunit 3 Ages F (3, 41) 5 7.68, p 5 0.004).
The proportion of GluR1 slightly decreased in the aged samples
(ANOVA F (1,10) 5 8.87, p 5 0.016; Tukey p , 0.05), whereas
the GluR3 showed a tendency to increase (ANOVA F (1,10) 5
7.6, p 5 0.02; Tukey p , 0.05). When the modifications (versus
adult) were considered individually (Fig. 7B), a predominant
pattern was observed. In all six animals, GluR1 decreased
(ranging from –9 to –38%; mean, –18.4 6 13.4%), GluR3 in-
creased (ranging from 20 to 65%; mean, 39.8 6 15.3%), and
GluR2 showed no variations (mean, –2.6 6 4.5%). However,
despite these age-dependent modifications, we found no signif-
icant differences between either ages in the (GluR1 1 GluR3)/
GluR2 ratio (GluR4 is a minor component of the AMPA recep-
tor): 1.57 6 0.17, n 5 4, and 1.55 6 0.17, n 5 6, for adult and
aged hippocampus, respectively (Fig. 7). Thus, the calcium
permeability of the AMPA receptors seems not to be altered
during aging.
We also quantified the relative proportion between the flip/
flop splicing version of each subunit. No differences were ob-
served (not shown).
Finally, the total expression of the AMPA receptor (GluR1 1
GluR2 1 GluR3 1 GluR4 subunits) were determined in rela-
tion to the expression of the b-actin. As shown in Fig. 8, no
age-dependent modifications were detected (AMPA/b-actin ra-
tio: 0.31 6 0.04, n 5 4, and 0.34 6 0.05, n 5 6, for adult and
aged hippocampus, respectively).
Expression of the GAD65/67 Isoenzymes—The expression of
both isoforms of the GAD enzyme (GAD65 and GAD67) was
also analyzed using the same experimental approach as for the
AMPA receptor in the same adult and aged samples. The re-
sults (Fig. 8) indicate the absence of significant differences
between both ages.
TABLE II
Total benzcdiazepine binding activity and anti-g2 or anti-a1 immunoprecipitation in adult and aged hippocampus
The isolated hippocampal membranes were solubilized, and the total binding activity of 10 nM [3H]flumazenil were determined. For immuno-
precipitation experiments, 150 mg of solubilized proteins were immunoprecipitated by two sequential incubations with 50 ml 1 50 ml of anti-g2 or
10 ml 1 10 ml of anti-a1. The binding activity (10 nM [3H]flumazenil) was determined in both pellets and in the final supernatant. The results
(mean 6 S.D.) represent the binding activity of the solubilized receptor (total binding) or the cumulative immunoprecipitation and are expressed
in pmol/mg solubilized protein or percentage of immunoprecipitation.
Age n
Solubilized
receptor total
binding
[3H]Flumazenil binding activity: cumulative Immunoprecipitation
Anti-g2 Anti-a1
pmol/mg protein pmol/mg protein % pmol/mg protein %
3 months 4 1.51 6 0.14 1.36 6 0.07 90.9 6 4.60 0.81 6 0.06 54.5 6 3.8
24 months 4 1.15 6 0.08a 1.05 6 0.08b 91.5 6 3.03 0.74 6 0.07 65.1 6 5.6c
a Significant decrease from adult ANOVA F(1,6) 5 15.13, p 5 0.008; Tukey p , 0.05.
b Significant decrease from adult ANOVA F(1,6) 5 33.47, p 5 0.0001; Tukey p , 0.01.
c Significant increase from adult ANOVA F(1,6) 5 9.75, p 5 0.02; Tukey p , 0.05.
FIG. 6. Immunoprecipitation curves of the anti-g2 antibody in
adult and aged hippocampus. The adult and aged hippocampal
membranes were solubilized, and a fixed amount of [3H]flumazenil (10
nM) binding activity (7, 500 6 500 cpm), equal for both ages, was
immunoprecipitated with increasing volumes of anti-g2 antiserum. Af-
ter immunprecipitation, the supernatants were collected and the bind-
ing activity was determined. The results, expressed as a percentage of
the binding activity in absence of antibody, are shown as mean 6 SD of
three different experiments in adults or individually for the aged rats.
All experiments were performed in duplicate.
FIG. 7. Expression of the AMPA subunits in adult and aged rat
hippocampus. A, shown is the proportion of the GluR1–4 AMPA
receptor subunits expressed in the adult (open circles) and aged (closed
circles) rat hippocampus. The results are shown individually and as
mean 6 SD (bars) of at least five adult and six aged rats. B, the
percentage of variation (in relation to the adult values) of GluR1,
GluR2, and GluR3 subunits was determined individually for each an-
alyzed rat. The coefficient of variation of these subunits in the adult
samples was also indicated in the figure.
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DISCUSSION
In this study, we have determined the expression of eight
subunits of the GABAA receptor and all four subunit of the
AMPA receptor in hippocampus from adult and six aged rats.
Age-dependent Modifications in the Expression of the GABAA
and AMPA Receptors—The main observation of this work is the
existence of an age-related increase on the expression of the
g2S subunit and, to a minor degree, in the a1 subunit of the
hippocampal GABAA receptor, in absence of major modification
of the AMPA receptor, in the same aged hippocampi.
The mRNA (short version) and protein of the g2 subunit
increased dramatically in all aged hippocampal samples. Thus,
in our rat population, the increase in the expression of the g2
subunit could be considered a hallmark of the aging process of
the hippocampal GABAA receptor. On the other hand, the
expression of the different a subunits also increases with aging;
however, this increase is lower in magnitude and also varies
between the different aged animals. In most cases, two differ-
ent a subunits increased; an increase in a1 subunit (mRNA and
protein) was the most common pattern. The reason for this
heterogeneous profile is not clear, but this profile likely means
that critical variables affecting the GABAA subunit expression
are different in the different aged rats (see below).
The age-dependent modifications in the pharmacological (8,
9) and the electrophysiological (11) properties of the GABAA
receptor are analogous to those found in the substantia nigra in
response to degeneration of the GABAergic striatal afferents
(34, 35). Indeed, the observed age-dependent increase in the
expression of the different GABAA receptor subunits in the
hippocampus could represent a normal response of the neurons
to a deafferentiation process. Interestingly, Shetty and Turner
(15) have demonstrated a decrease in the number of the
GABAergic neurons at the hippocampal formation of the aged
rats. Thus, a decline in the number of the interneurons could
indicate a reduction of the GABAergic inputs to the principal
cells and, consequently, an increase of the expression of the
GABAA receptor complex. However, in our adult and aged
hippocampi, no apparent differences in the expression of both
GAD isoenzymes were observed. This discrepancy does not
invalidate our hypothesis because: (i) a deafferentiation proc-
ess, without net neuronal loss, would result in an increase of
the expression of the GABAA receptor, or (ii) it is possible that
the surviving interneurons increase the expression of these
isoenzymes compensating for the loss in the neuronal number
(1). Thus, we propose that the age-dependent increase of the
expression of the GABAA receptor subunits constitutes a nor-
mal adaptive response of the principal cells to deficiencies on
the GABAergic system.
On the other hand, the age-dependent reduction in the
GABAergic cell number also was heterogeneous (15). There-
fore, it is tempting to speculate that the high interanimal
heterogeneity found in the expression of the different a sub-
units may reflect the reduction of different GABAergic popula-
tions and/or deafferentiation of a particular subset of synaptic
contact in the principal cells of the aged hippocampus. In con-
sequence, depending on the different GABAergic synapses af-
fected, the adaptive response may differ in the different ani-
mals. It is important to emphasize the dramatic increase in the
expression of the g2 subunit (mRNA and protein) in all tested
aged hippocampi, indicating the existence of a similar process
in the whole aged population.
Our results also demonstrated the absence of major modifi-
cations on the expression of the hippocampal AMPA receptor
subunits in the same animals. The absence of such modifica-
tions is consistent with previous reports demonstrating the
absence of changes of the [3H]AMPA binding sites at the hip-
pocampal formation (12, 13, 36) and suggest the absence of
major modifications on the excitatory inputs. This proposal is
based on the fact that the expression of the AMPA receptor
subunits, GluR1 and GluR2/3, also increased after deafferen-
tiation (37). This conclusion is also in accordance with the
preservation of the principal neurons observed in the aged
animals (38).
We also observed a decrease in the relative proportion of the
GluR1 subunit concomitant with an increase in the GluR3
subunit. These modifications might reflect an increase on the
excitability of the aged hippocampus, because similar alter-
ations (decrease in GluR1 and increase in GluR3) have been
reported in response to lesion-induced limbic seizures (39) or in
a pilocarpine model of spontaneous limbic epilepsy (40).
As a whole, the observed age-dependent modifications in the
expression of both GABAA and AMPA receptor subunits
FIG. 8. Absence of variation on the
expression of the total AMPA recep-
tor subunits and both GAD isoen-
zymes in the aged hippocampus. The
expression of total AMPA receptor sub-
units (GluR1 1 GluR2 1 GluR3 1 GluR4)
and both GAD isoenzymes (GAD65 and
GAD67) were determined in relation on
the expression of the b-actin. The results
(mean 6 SD) from four adult and six aged
samples are expressed as the percentage
of variation versus adult. For the b-actin,
the PCR products from both ages were
directly compared. Also, the age-depend-
ent variation on the g2S subunit of the
GABAA receptor was determined, in par-
allel, as internal control of the method.
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strongly suggest a preferential age-dependent alteration of the
GABAergic cells that could suggest a decrease in the inhibitory
system (see also Refs. 1, 41, and 42).
Age-dependent Modifications of the Mature GABAA Recep-
tor—The increase in the expression of both a1 and g2 subunit,
mRNA, and protein could have a direct repercussion on the
mature GABAA receptor in membranes. Thus, we investigated
the anti-a1 and anti-g2 immunoprecipitation of the [3H]fluma-
zenil binding activity, solubilized from isolated membranes. We
presume that only mature (assembled) GABAA receptors dis-
play benzodiazepine binding sites (43, 44). In fact, our immu-
noprecipitation experiments demonstrated that the increased
expression of the a1 subunit was directly reflected by an in-
crease in the proportion of GABAA receptor containing this
subunit in the aged hippocampus, confirming previous phar-
macological and immunological experiments (8–10). Therefore,
the increased transcripted and translated a1 subunit is incor-
porated into the assembled receptor, modifying the pharmaco-
logical and electrophysiological properties of the GABAA recep-
tor (8, 9, 11).
On the other hand, the increased expression of the g2 sub-
unit is not reflected by modifications in the mature GABAA
receptor complex. The reduction of both the total and the an-
ti-g2 immunoprecipitated [3H]flumazenil binding activity could
indicate the existence of an increase in the unassembled, or
partially assembled, g2 subunits (displaying no benzodiazepine
binding activity) as confirmed by the increase in the anti-g2
antibody volume that produced a half-maximal immunopre-
cipitation in the aged hippocampus. Therefore, the increase on
the expression of the g2 subunit could result in an accumula-
tion of this subunit in, probably, intracellular compartments.
We do not know the reasons for this differential effect of aging
on the incorporation of the a1 and g2 subunits to the mature
receptors, but the extremely high increase on the expression of
the g2 subunit, more than 12 times higher than that of the a
subunits (see Table I) in the absence of apparent modifications
in the expression of the b subunits, could exceed the capacity of
the assembling process of the GABAA receptor.
In conclusion, our results demonstrated the existence of an
age-dependent increase on the expression of the GABAA recep-
tor subunits in the hippocampal formation with minor modifi-
cations on the expression of the AMPA receptor. These modifi-
cations indicate the existence of an specific alteration (neuronal
loss and/or deafferentiation) in the GABAergic system.
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